首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >In vitro and in vivo antitumor activity of platinum(II) complexes with thiosemicarbazones derived from 2-formyl and 2-acetyl pyridine and containing ring incorporated at N(4)-position: synthesis, spectroscopic study and crystal structure of platinum(
【24h】

In vitro and in vivo antitumor activity of platinum(II) complexes with thiosemicarbazones derived from 2-formyl and 2-acetyl pyridine and containing ring incorporated at N(4)-position: synthesis, spectroscopic study and crystal structure of platinum(

机译:铂(II)与2-甲酰基和2-乙酰基吡啶并在N(4)-位处掺入环的硫代半氨基甲酮类化合物的体外和体内抗肿瘤活性:铂的合成,光谱研究和晶体结构

获取原文
获取原文并翻译 | 示例
           

摘要

Reactions of thiosemicarbazones of 2-formyl and 2-acetyl pyridine and containing an azepane ring (hexamethyleneiminyl ring) incorporated at N(4)-position, HL(1) (1) and HL(2) (2) with platinum(II) afforded the complexes, [Pt(L(1))Cl] (3) and [Pt(L(2))Cl] (4). Characterization of the compounds was accomplished by means of elemental analysis and spectroscopic techniques NMR, UV-vis and IR spectroscopy. The single-crystal X-ray structure of complex [Pt(L(2))Cl] (4) shows that the ligand monoanion coordinates in a planar conformation to the metal via the pyridyl N atom, the imine-N atom, and thiolato S-atom. Compounds 1-4 have been evaluated for antiproliferative activity in vitro against three human cancer cell lines: MCF-7 (human breast cancer cell line), T24 (bladder cancer cell line), A-549 (non-small cell lung carcinoma) and a mouse L-929 (a fibroblast-like cell line cloned from strain L). Ligand 2 exhibited high activity as anticancer agent against all four cancer cell lines, while ligand 1 exhibitedselectivity against MCF-7, L-929 cell lines and complex 4 against A-549, T-24 cancer cell lines. Also, the acute toxicity and antitumor activity were evaluated on leukemia P388-bearing mice. Complex 3 afforded five to six cures against leukemia P388. The in vivo results of the antitumor activity show the two platinum complexes as very effective chemotherapeutic antileukemic agents.
机译:2-甲酰基和2-乙酰基吡啶并在N(4)-位,HL(1)(1)和HL(2)(2)处并入的氮杂环戊烷环(六亚甲基亚甲基环)的硫代半氨基甲酮与铂(II)的反应提供了[Pt(L(1))Cl](3)和[Pt(L(2))Cl](4)的配合物。通过元素分析和光谱技术NMR,UV-vis和IR光谱法完成化合物的表征。配合物[Pt(L(2))Cl](4)的单晶X射线结构表明,配位体单阴离子通过吡啶基N原子,亚胺-N原子和硫醇基与金属形成平面构型。 S原子已评估化合物1-4对三种人类癌细胞系的体外抗增殖活性:MCF-7(人类乳腺癌细胞系),T24(膀胱癌细胞系),A-549(非小细胞肺癌)和小鼠L-929(从菌株L克隆的成纤维细胞样细胞系)。配体2表现出对所有四种癌细胞系的抗癌剂的高活性,而配体1表现出对MCF-7,L-929细胞系的选择性以及复合物4表现出对A-549,T-24癌细胞系的选择性。此外,还对携带白血病P388的小鼠进行了急性毒性和抗肿瘤活性的评估。复合物3提供了五到六种针对白血病P388的治疗方法。体内抗肿瘤活性的结果表明两种铂配合物是非常有效的化疗抗白血病药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号